Results 211 to 220 of about 18,452 (302)

Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats [PDF]

, 2004
Waldemar Urbanowicz
openalex   +1 more source

Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants. [PDF]

Cochrane Database Syst Rev, 2016
More K, Athalye-Jape GK, Rao SC, Patole SK.   +3 more
europepmc   +1 more source

Cardioprotective and Anti‐Hypertensive Effects of Epigallocatechin Gallate: Novel Insights Into Biological Evidence

The Journal of Clinical Hypertension, Volume 27, Issue 6, June 2025.
ABSTRACT Epigallocatechin gallate (EGCG), the major catechin in green tea, is of considerable interest principally due to its proposed antihypertensive and cardioprotective properties. New research shows that EGCG can help relax the circulation of blood vessels, reduce arterial stiffness of arteries, and promote antioxidant activity promotion, which ...
Reza Eshraghi, Ashkan Bahrami, Faraz Tayyar Iravanlou, Mehdi Karimi, Mohammad Saeed Soleimani, Mohammad Hossein Paknahad, Mohammad Yaghoubi, Arman Beheshtirooy, Fatemeh Qasemi Talouki, Javad Shaabanzadeh, Fatemeh Hasani, Alireza Rafi, Mohammad Hossein Pourhanifeh   +12 more
wiley   +1 more source

Functional Role of Endogenous Endothelin-1 in Congestive Heart Failure Treated with Angiotensin II Receptor Antagonist.

, 2001
Kaoru Dohi, Katsuya Onishi, Tetsuya Kitamura, Tsutomu Okinaka, Masaaki Ito, Naoki Isaka, Takeshi Nakano   +6 more
openalex   +2 more sources

Multiomics‐Driven Drug‐Cell Interaction Network for Chemotherapy Sensitivity Prediction in Metabolically Defined Triple‐Negative Breast Cancer Subtypes

Journal of Cellular and Molecular Medicine, Volume 29, Issue 11, June 2025.
ABSTRACT Triple‐negative breast cancer (TNBC) is associated with a poor prognosis due to insufficient molecular subtyping precision and limited actionable targets. Although metabolic reprogramming underlies TNBC chemotherapy resistance, establishing metabolic subtyping systems and investigating drug sensitivity across distinct metabolic subgroups could
Jingyuan Zhang, Xuejun Sun
wiley   +1 more source

THE USE OF THE ENDOTHELIN RECEPTOR ANTAGONIST, TEZOSENTAN, BEFORE OR AFTER RENAL ISCHEMIA PROTECTS RENAL FUNCTION1

, 2001
S M Wilhelm, Nicholas T. Stowe, Ann Robinson, James A. Schulak   +3 more
openalex   +1 more source

The role of transient receptor potential melastatin channels in compressive force‐induced contraction of primary cardiac pericytes

Physiological Reports, Volume 13, Issue 12, June 2025.
Abstract Pericytes contract during acute myocardial infarction (AMI) resulting in capillary constriction, which further contributes to the ischemic damage and enlargement of infarct size. We hypothesized that increased intramyocardial pressure during ischemia can be sensed by mechanosensitive Transient Receptor Potential (TRP) channels in cardiac ...
Carmen Methner, Eugene Cilento, Zhiping Cao, Jeffrey Iliff, Anusha Mishra, Sanjiv Kaul   +5 more
wiley   +1 more source

Entry-Into-Humans Study with Tezosentan, an Intravenous Dual Endothelin Receptor Antagonist

, 2002
Jasper Dingemanse, Martine Clozel, Paul L. M. van Giersbergen   +2 more
openalex   +1 more source

1436: Bosentan, an Endothelin Dual Receptor Antagonist, Potentiates Nitric Oxide-Mediated Erectile Response in an Aging Brown-Norway Rat Model [PDF]

, 2004
Steven White, Michael Albo, Mahadevan Rajasekaran   +2 more
openalex   +1 more source

Wound, pressure ulcer, and burn guidelines (2023)―4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers, third edition

The Journal of Dermatology, Volume 52, Issue 6, Page e430-e480, June 2025.
Yoshihide Asano, Jun Asai, Takayuki Ishii, Yohei Iwata, Masanari Kodera, Chie Miyabe, Akihiko Uchiyama, Youichi Ogawa, Ken Okamura, Mari Kishibe, Yuta Koike, Yorihisa Kotobuki, Noriki Fujimoto, Takuya Miyagi, Yukie Yamaguchi, Ayumi Yoshizaki, Reiko Omori, Takeshi Nakanishi, Hiroshi Fujiwara, Takeo Maekawa, Sei‐ichiro Motegi, Yuichiro Yoshino, Minoru Hasegawa, Manabu Fujimoto, Takao Tachibana, Wound, Pressure Ulcer, and Burn Guidelines Drafting Committee (connective tissue disease/vasculitis group)   +27 more
wiley   +1 more source